Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Using old drugs for new uses can help treat rare immune deficiencies.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Targeting NETs may help reduce fibrosis in Crohn's disease.

B cells can both help and hinder the body's defense against melanoma.

CD271 is crucial for maintaining healthy skin and preventing inflammation.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

TAK-279 effectively reduces psoriasis symptoms and is safe.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Using a combination of AMD3100 and FK506 can speed up and improve wound healing in diabetic rats.

Topical IKKα inhibitors may help prevent CCS tumours.